Prévisions du marché des opioïdes au Moyen-Orient et en Afrique jusqu\'en 2030 - Analyse régionale - par produit (opioïde à libération immédiate à action brève et opioïde à libération prolongée à action prolongée), application (gestion de la douleur, anesthésie, suppression de la diarrhée, suppression de la toux, désintoxication et autres), voie d\'administration (voie orale, injectable et patch transdermique) et canal de distribution (pharmacies hospitalières et pharmacies de détail)
L\'augmentation de l\'incidence de la douleur chronique renforce le marché des opioïdes au Moyen-Orient et en Afrique
Les maladies chroniques telles que les maladies cardiovasculaires, le cancer, les maladies musculo-squelettiques et les maladies neurovasculaires affectent gravement la santé d\'une personne en diminuant l\'immunité. De plus, de nombreux patients souffrant de ces affections souffrent de douleurs chroniques. Les maladies mentionnées ci-dessus sont plus courantes chez les adultes et la population gériatrique. Néanmoins, les cas de ces maladies augmentent également sensiblement chez les enfants. La douleur chronique est également courante chez les sportifs, les athlètes et les personnes vivant avec des blessures antérieures. Selon une étude publiée dans le NCBI (National Center for Biotechnology Information), 20 % des adultes souffrent de douleurs dans le monde et 10 % reçoivent un nouveau diagnostic de douleur chronique chaque année. Bien que la douleur affecte toutes les populations, indépendamment du sexe, de la race/ethnicité, du revenu, de l\'âge ou de la géographie, elle n\'est pas répartie de manière égale à travers le monde. Les opioïdes sur ordonnance, notamment l\'hydrocodone, l\'oxycodone et la morphine, sont de puissants analgésiques utilisés pour traiter la douleur causée par des blessures, des interventions chirurgicales et des problèmes de santé tels que le cancer et l\'arthrite.
Selon le Congressional Research Service, les Américains pourraient obtenir plus d\'opioïdes au détriment de thérapies antidouleur plus complètes. L\'augmentation des pratiques de prescription d\'opioïdes peut être attribuée aux programmes de remboursement des assurances qui encouragent les opioïdes par rapport aux traitements alternatifs contre la douleur, aux structures de coûts qui encouragent des soins plus efficaces et aux évaluations qui combinent la satisfaction des patients avec une gestion efficace de la douleur. Par conséquent, en raison de l\'avantage des opioïdes dans la gestion de la douleur, la demande augmente chez les patients atteints de maladies chroniques.
Aperçu du marché des opioïdes au Moyen-Orient et en Afrique
Le marché des opioïdes au Moyen-Orient et en Afrique est segmenté en Afrique du Sud, aux Émirats arabes unis, en Arabie saoudite et dans le reste du Moyen-Orient et de l\'Afrique. Au Moyen-Orient et en Afrique, les opioïdes sont utilisés pour le soulagement de la douleur, les soins palliatifs et la désintoxication des opioïdes. La norme de soins pour les troubles liés à l\'utilisation d\'opioïdes implique un traitement à l\'aide de médicaments tels que la méthadone, la buprénorphine ou la naltrexone ; ces médicaments pour les troubles liés à l\'utilisation d\'opioïdes (MOUD) réduisent les décès par surdose d\'opioïdes. En 2020, le MOUD n\'était disponible comme modalité de traitement pour les troubles liés à l\'utilisation d\'opioïdes qu\'au Liban, au Maroc, en Iran et dans les Territoires palestiniens. Malgré le développement économique et des soins de santé croissant dans quelques pays de la région, il y a eu une augmentation limitée de la consommation d\'opioïdes au Moyen-Orient et en Afrique.
Chiffre d\'affaires et prévisions du marché des opioïdes au Moyen-Orient et en Afrique jusqu\'en 2030 (en millions de dollars américains)
Segmentation du marché des opioïdes au Moyen-Orient et en Afrique
Le marché des opioïdes au Moyen-Orient et en Afrique est classé en produit, application, voie d\'administration, canal de distribution et pays.
En fonction du produit, le marché des opioïdes au Moyen-Orient et en Afrique est segmenté en opioïdes à libération immédiate à courte durée d\'action et opioïdes à libération prolongée à longue durée d\'action. Le segment des opioïdes à libération immédiate à courte durée d\'action détenait une part de marché plus importante en 2022. L\'opioïde à libération immédiate à courte durée d\'action est en outre sous-segmenté en oxycodone, hydrocodone, tramadol, codine, propoxyphène et autres. L\'opioïde à libération prolongée à longue durée d\'action est en outre sous-segmenté en oxycodone, fentanyl, morphine, méthadone et autres.
En termes d\'application, le marché des opioïdes du Moyen-Orient et de l\'Afrique est classé en gestion de la douleur, anesthésie, suppression de la diarrhée, suppression de la toux, désintoxication et autres. Le segment de la gestion de la douleur détenait la plus grande part de marché en 2022.
Par voie d\'administration, le marché des opioïdes du Moyen-Orient et de l\'Afrique est segmenté en patch oral, injectable et transdermique. Le segment oral détenait la plus grande part de marché en 2022.
Par canal de distribution, le marché des opioïdes du Moyen-Orient et de l\'Afrique est divisé en pharmacies hospitalières et pharmacies de détail. Le segment des pharmacies hospitalières détenait une part de marché plus importante en 2022.
Par pays, le marché des opioïdes du Moyen-Orient et de l\'Afrique est segmenté en Arabie saoudite, Afrique du Sud, Émirats arabes unis et reste du Moyen-Orient et de l\'Afrique. L\'Afrique du Sud a dominé la part de marché des opioïdes au Moyen-Orient et en Afrique en 2022.
Neuraxpharm Pharmaceuticals SL, Endo International plc, Hikma Pharmaceuticals Plc, Mallinckrodt Plc, Rusan Pharma Ltd et Teva Pharmaceutical Industries Ltd sont quelques-unes des principales sociétés opérant sur le marché des opioïdes au Moyen-Orient et en Afrique.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Middle East & Africa Analysis
5.1 Middle East & Africa Opioids Market Overview
5.2 Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030
5.3 Middle East & Africa Opioids Market Forecast Analysis
6. Middle East & Africa Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Middle East & Africa Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Opioids Market - Country Analysis
10.1 Middle East & Africa
10.1.1 Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.2.4 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.2.5 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.2.6 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.3 South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.3.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.3.4 South Africa: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.3.5 South Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.3.6 South Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.4 United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.4.2 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.4.4 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.4.5 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.4.6 United Arab Emirates: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
10.1.1.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Product
10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Application
10.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Route Of Administration
10.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Opioids Market Segmentation
Table 2. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 15. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 19. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 21. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 31. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route Of Administration
Table 33. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Recent Organic Growth Strategies in Opioids Market
Table 35. Recent Inorganic Growth Strategies in the Opioids Market
Table 36. Glossary of Terms, Opioids Market
List of Figures
Figure 1. Middle East & Africa Opioids Market Segmentation, by Country
Figure 2. Middle East & Africa Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Middle East & Africa Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Middle East & Africa Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Middle East & Africa Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa Opioids Market, by Key Countries, Revenue (2022) (US$ Million)
Figure 23. Middle East & Africa: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. Saudi Arabia: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. United Arab Emirates: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Middle East & Africa: Middle East & Africa Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Opioids Market
- Neuraxpharm Pharmaceuticals SL
- Endo International plc
- Hikma Pharmaceuticals Plc
- Mallinckrodt Plc
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa opioids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa opioids market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.